1. Alteration of cholesterol distribution at the plasma membrane of cancer cells: From evidence to pathophysiological implication and promising therapy strategy
   Mauriane Maja et al, 2022, Frontiers in Physiology CrossRef
2. β‐elemene increases the sensitivity of gastric cancer cells to TRAIL by promoting the formation of DISC in lipid rafts
   Ling Xu et al, 2018, Cell Biology International CrossRef
3. The multifaceted role of TRAIL signaling in cancer and immunity
   Ludmila Cardoso Alves et al, 2021, The FEBS Journal CrossRef
4. Expression of sphingomyelin synthase 1 (SGMS1) gene varies in human lung and esophagus cancer
   A. V. Rozhkova et al, 2014, Molecular Biology CrossRef
5. Lewis glycosphingolipids as critical determinants of TRAIL sensitivity in cancer cells
   Tomoya Fukuoka et al, 2022, Oncogene CrossRef
6. Current approaches in enhancing TRAIL therapies in glioblastoma
   Morrent Thang et al, 2023, Neuro-Oncology Advances CrossRef
7. TRAIL receptor-induced features of epithelial-to-mesenchymal transition increase tumour phenotypic heterogeneity: potential cell survival mechanisms
   Ludovic Peyre et al, 2021, British Journal of Cancer CrossRef
8. β-catenin decreases acquired TRAIL resistance in non-small-cell lung cancer cells by regulating the redistribution of death receptors
   Chengcheng You et al, 2018, International Journal of Oncology CrossRef
9. Therapeutic applications of TRAIL receptor agonists in cancer and beyond
   Gustavo P. Amarante-Mendes et al, 2015, Pharmacology & Therapeutics CrossRef
10. miR‐200a enhances TRAIL‐induced apoptosis in gastric cancer cells by targeting A20
    Tianshu Guo et al, 2018, Cell Biology International CrossRef
11. The Case Back on the TRAIL: Death Receptors as Markers for rhTRAIL Sensitivity
    Katherine A Turner et al, 2017, The Journal of Applied Laboratory Medicine CrossRef
12. Cetuximab enhances TRAIL-induced gastric cancer cell apoptosis by promoting DISC formation in lipid rafts
    Ling Xu et al, 2013, Biochemical and Biophysical Research Communications CrossRef
13. Sphingolipids: Key Regulators of Apoptosis and Pivotal Players in Cancer Drug Resistance
    Paola Giussani et al, 2014, International Journal of Molecular Sciences CrossRef
14. Next-generation Tumor-homing Induced Neural Stem Cells as an Adjuvant to Radiation for the Treatment of Metastatic Lung Cancer
    Alison R. Mercer-Smith et al, 2022, Stem Cell Reviews and Reports CrossRef
15. CDH1 overexpression sensitizes TRAIL resistant breast cancer cells towards rhTRAIL induced apoptosis
    Poulami Tapadar et al, 2023, Molecular Biology Reports CrossRef
16. TRAIL–Receptor Costimulation Inhibits Proximal TCR Signaling and Suppresses Human T Cell Activation and Proliferation
    Corinna Lehnert et al, 2014, The Journal of Immunology CrossRef
17. Fas/CD95, Lipid Rafts, and Cancer
    Faustino Mollinedo et al, 2017, TRAIL, Fas Ligand, TNF and TLR3 in Cancer CrossRef
18. Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization
    Joshua D Greenlee et al, 2021, eLife CrossRef
19. Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies
    M Marconi et al, 2013, Cell Death & Disease CrossRef